# Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma

> **NCT02614534** · PHASE3 · UNKNOWN · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 200 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** MITOMYCIN-C 30 mg
- **PROCEDURE:** Proactive cytoreductive surgery

## Key facts

- **NCT ID:** NCT02614534
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11-16
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02614534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02614534, "Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02614534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*